New Advances in Relapsed/Refractory Multiple Myeloma: Current Guidance and Future Perspectives

In this podcast episode, listen to myeloma experts Natalie S. Callander, MD, and Shaji Kumar, MD, respond to audience questions from a live CCO Webinar discussing current guidelines and treatment advances for patients with relapsed/refractory multiple myeloma.

Shaji K. Kumar, MD
Program Director Natalie S. Callander, MD Released: September 1, 2020

Downloadable slides with expert analysis of treatment strategies for heavily pretreated relapsed/refractory multiple myeloma.

Shaji K. Kumar, MD
Program Director Released: June 25, 2020

Downloadable slides with expert analysis of investigational agents and combinations for heavily pretreated relapsed/refractory multiple myeloma

Natalie S. Callander, MD Released: June 25, 2020

In this interactive, on-demand Webcast, hematology experts review the current guidelines and new treatment advances for patients with relapsed/refractory multiple myeloma and discuss patient cases and new data from the 2020 ASCO Virtual Scientific Meeting.

Shaji K. Kumar, MD
Program Director Natalie S. Callander, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: September 14, 2020 Expired: September 13, 2021

Overview of Relapsed/Refractory Myeloma and Therapeutic Strategies for Patients With Heavily Pretreated Disease After Relapse (29 mins)

Promising New Treatment Options for Patients With Relapsed/Refractory Myeloma (26 mins)